Home
Clinical Trials
Diagnosis of PCL With EUS-FNA...

Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Last Updated: 2019-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

58 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-02-01

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pancreatic cystic lesions (PCLs) comprise of a heterogeneous group of entities that are benign, premalignant or malignant. With increased use of modern imaging techniques in recent years, incidentally discovered PCL have become much more common. However, imaging modalities for characterising PCL is a known clinical uncertainty since imaging is capable of detecting these lesions but may often not be able to distinguish malignant from benign lesions. Incorrect assessment of PCL can lead to fatal consequences because a malignant lesion may not be treated and a benign may be unnecessarily resected. The aim of this study was to assess the performance of endoscopic ultrasound with fine-needle aspiration (EUS-FNA) in the diagnosis of pancreatic cystic lesions compared to cross-sectional imaging modalities (CT/MRI). Our hypothesis is that EUS-FNA has a higher accuracy for diagnosing PCLs compared with cross-sectional imaging.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

NCT03492151

Pancreatic Cyst

RECRUITING

New Biomarkers in the Intracystic Liquid of Inflammatory and Non-inflammatory Pancreatic Cysts

NCT05568433

Pancreatic Cyst

COMPLETED

Confirmation of Association Between Cystic Fluid Analysis With Pancreatic Cystic Lesions

NCT05497271

Pancreatic Cyst Molecular, Chemical Analysis of Cystic Fluid

RECRUITING

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

NCT06867172

Pancreatic Steatosis Pancreatic Cyst Pancreatic Adenocarcinoma

RECRUITING

Endoscopic Ultrasound Elastography in Pancreatic Masses

NCT00909103

Pancreatic Adenocarcinoma Chronic Pancreatitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Cyst Pancreatic Neuroendocrine Carcinoma Pancreatic Pseudocyst Pancreatic Serous Cystadenoma Pancreatic Mucinous Cystadenoma Pancreatic Cystadenocarcinoma Pancreatic Intraductal Papillary-Mucinous Neoplasm Solid Pseudopapillary Tumor of the Pancreas

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with suspected PCLs according to radiology undergoing evaluation with EUS-FNA at a tertiarry endoscopy center from February 2007 until March 2017, who underwent pancreas resection

Oral and written consent of patients examined